Blood pressure influences end-stage renal disease of Cd151 knockout mice

Norman Sachs1, Nike Claessen, Jan Aten

  • 1Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Insights

CD151 is essential for podocyte adhesion to the kidney's glomerular basement membrane. Its absence causes kidney disease, especially under high blood pressure, highlighting CD151's role in renal health.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Medicine

Background:

  • Podocytes are crucial for kidney filtration, relying on adhesion to the glomerular basement membrane (GBM).
  • Integrin-α3β1, laminin, and actin are key components of the podocyte-GBM binding axis.
  • Previous studies highlighted the roles of integrin-linked kinase, laminin-521, and α-actinin 4 in podocyte adhesion.

Purpose of the Study:

  • To investigate the role of tetraspanin CD151 in podocyte adhesion to the GBM.
  • To determine the impact of CD151 deletion on kidney function and nephropathy.
  • To explore the influence of blood pressure on CD151-related kidney disease.

Main Methods:

  • In situ interaction analysis of integrin α3β1 and CD151 in human podocytes.
  • CRISPR-Cas9 mediated deletion of Cd151 in mouse glomerular epithelial cells.
  • In vivo studies involving podocyte-specific Cd151 deletion and global Cd151-null mice under varying pressures.
  • Pharmacological intervention with angiotensin-converting enzyme blockers.

Main Results:

  • Integrin α3β1 interacts with CD151 in human podocytes.
  • Cd151 deletion in mouse podocytes reduced adhesion to laminin by altering α3β1 distribution.
  • Podocyte-specific Cd151 deletion induced glomerular nephropathy in mice.
  • Elevated blood pressure exacerbated nephropathy in global Cd151-null mice.
  • ACE inhibition prolonged survival in susceptible Cd151-null mice.

Conclusions:

  • CD151 is a critical regulator of integrin-mediated podocyte adhesion to the GBM.
  • CD151 deficiency leads to nephropathy, particularly when combined with increased blood pressure.
  • Blood pressure is a significant factor in the pathogenesis of Cd151 knockout-induced nephropathy.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...